Quarterly results, annual reports, SEC filings, news, stock info, stock quote, stock chart, historical stock quote, investment calculator, dividend & split ...

Raises Full-Year 2024 Revenue Guidance(1) to a Range of $61.0 to $64.0 Billion and Raises Adjusted(2). Diluted EPS Guidance to a Range of ...

29 окт. 2024 г. · The company reported revenues of $17.7 billion in the third quarter, representing 32% year-over-year operational growth. Excluding the company's ...

2024 FINANCIAL GUIDANCE(1) Pfizer raises full-year 2024 revenue guidance by $1 billion at the midpoint to a range of $59.5 to $62.5 billion and raises Adjusted ...

16 авг. 2024 г. · ... 2024 Highlights. 4. Financial. Statements. Annual Report 2023-24. Statutory. Reports. Page 5. Breakthroughs that change patients' lives.

29 окт. 2024 г. · Pfizer raises full-year 2024 revenue guidance by $1.5 billion at the midpoint to a range of $61.0 to $64.0 billion and raises Adjusted (2) diluted EPS guidance ...

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide.

FINANCIAL INFORMATION ; 2024-2025 · Unaudited Results – Quarter ended September 30, 2024 ; 2023-2024 · Annual Report 2023 – 24 ; 2022-2023 · AGM held on August 18, ...

30 янв. 2024 г. · Pfizer expects full-year 2024 revenues(2) to be in the range of $58.5 to $61.5 billion, which includes approximately $8 billion in anticipated ...

Get the detailed quarterly/annual income statement for Pfizer Inc. (PFE). Find out the revenue, expenses and profit or loss over the last fiscal year.